InvestorsHub Logo
Followers 16
Posts 2999
Boards Moderated 2
Alias Born 09/15/2017

Re: None

Tuesday, 06/19/2018 11:07:34 AM

Tuesday, June 19, 2018 11:07:34 AM

Post# of 205098
Massive for all who are new to ARYC:

Arrayit CLIA clinical team confirms 7/2/2018 meeting with top officials at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA to discuss FDA regulatory clearance of a major microarray technology product line fda.gov

Arrayit has developed an advanced blood card technology that collects and fractionates whole blood into red blood cells, white blood cells and serum components quickly, easily and affordably. Our unique linear separation chromatography process collects 5 droplets of whole blood and separates and dries the whole blood components in 10 minutes. Arrayit Blood Cards can be used to fractionate, ship, sample and store samples for a variety of applications in research, veterinary medicine and pathology including protein-based allergy testing and cancer research. Arrayit Blood Cards can also be used to isolate DNA and mRNA samples for genotyping and expression profiling applications. Private labeling is available for large OEM accounts.

http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html

July 2 is just 2 weeks away